In genetically engineered mouse models PTEN loss was found to cooperate with TMPRSS-ERG fusion, c-myc upregulation and loss of function of the NKX3.1 homeobox gene in promoting prostate tumorigenesis. The gene discussed is MYC; the disease is urogenital neoplasm.